However, we found that neoadjuvant chemotherapy could only slightly promote the infiltration of immune cells in the overall tumor area, among which the infiltration of CD4+ GzmB+ T cells were significantly increased in NCT group. The gene discussed is CD4; the disease is neoplasm.